Coral Laboratories Limited (BSE: 524506)
Health Care · Pharmaceuticals · IN
Rs572.25
+4.31% today · +12.7% 1Y
Coral Laboratories Limited (BSE: 524506) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.12M.
Over the last twelve months the share price has gained 12.7%, trading between 360.00 and 679.00.
Tweenvest scores Coral Laboratories Limited across four factors: quality 72/100, value 56/100, growth 0/100, dividend 41/100. Its strongest factor is quality.
524506 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.12M
- Revenue (TTM)
- $10.23M
- P/E
- 10.65
- EPS
- 53.75
- Dividend yield
- 0.35%
- Beta (5Y)
- 0.85
- 52-week high
- Rs679.00
- 52-week low
- Rs360.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.57M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
| Philadelphia Pharmaceuticals CompanyASE: PHIL | $21.16M | JD2.00 | +5.26% |
| MediPharm Labs Corp.TSX: LABS | $20.96M | CA$0.07 | 0.00% |
| Universe Pharmaceuticals INCNasdaqCM: UPC | $20.85M | $4.15 | -7.78% |
| Syschem (India) LimitedBSE: 531173 | $20.83M | Rs37.60 | +8.05% |
| Voyageur Pharmaceuticals Ltd.TSXV: VM | $20.62M | CA$0.13 | -7.14% |
Figures last refreshed Oct 11, 2026.